ATAI Life Sciences NV (ATAI)
1.71
+0.19
(+12.50%)
USD |
NASDAQ |
Nov 22, 12:06
ATAI Life Sciences Total Liabilities (Quarterly): 51.20M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 51.20M |
| June 30, 2024 | 47.24M |
| March 31, 2024 | 45.86M |
| December 31, 2023 | 49.16M |
| September 30, 2023 | 39.71M |
| June 30, 2023 | 37.96M |
| March 31, 2023 | 40.08M |
| December 31, 2022 | 39.68M |
| Date | Value |
|---|---|
| September 30, 2022 | 46.52M |
| June 30, 2022 | 28.81M |
| March 31, 2022 | 29.38M |
| December 31, 2021 | 28.21M |
| September 30, 2021 | 21.35M |
| June 30, 2021 | 21.07M |
| March 31, 2021 | 25.27M |
| December 31, 2020 | 16.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.18M
Minimum
Dec 2020
51.20M
Maximum
Sep 2024
35.48M
Average
38.82M
Median
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 25.43M |
| InflaRx NV | 16.09M |
| BioNTech SE | 3.671B |
| Immatics NV | 217.47M |
| CureVac NV | 144.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.52M |
| Shareholders Equity (Quarterly) | 145.72M |
| Debt to Equity Ratio | 0.1561 |
| Current Ratio | 5.807 |
| Net Debt Paydown Yield | -0.77% |